Alzheimer's stem cell study pulled before it began
NCT ID NCT04228666
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 31 times
Summary
This study aimed to test the safety of using a patient's own fat-derived stem cells to treat early Alzheimer's disease. Participants would have received four intravenous infusions of their own stem cells. However, the trial was withdrawn before enrolling anyone, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Trial Network
Houston, Texas, 77074, United States
Conditions
Explore the condition pages connected to this study.